| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cardiff Oncology, Inc. (CRDF) has 6 insiders with recent SEC Form 4 filings, including 11 buys and 1 sell. CRDF is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.33M | $2.18M | - | |
| Dir | 222.9K | $365.5K | - | |
| Dir | 187.5K | $307.6K | - | |
| Dir | 168.8K | $276.8K | - | |
| Dir | 168.8K | $276.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2021 | Armitage James O | Director | Buy | 4,000 | $10.82 | $43,271.20 | +38.1% | -31.8% | -77.6% | |
| Mar 18, 2021 | Pace Gary W66 | Director | Buy | 3,000 | $10.55 | $31,660.00 | +0.3% | -22.6% | -75.1% | |
| Mar 4, 2021 | Pace Gary W66 | Director | Buy | 1,500 | $9.27 | $13,897.50 | +0.3% | - | - | |
| Nov 23, 2020 | Kelemen Vicki | Exec. VP And COO | Sale+OE | 35,321 | $18.60 | $657,020.05 | -87.5% | - | - | |
| Sep 16, 2020 | Pace Gary W66 | Director | Buy | 2,550 | $5.70 | $14,526.50 | +0.3% | - | - | |
| May 14, 2020 | Erlander Mark | Chief Executive Officer | Buy | 6,993 | $1.43 | $9,999.99 | +109.7% | - | - | |
| May 14, 2020 | Adams Thomas Phd | Director | Buy | 13,986 | $1.43 | $19,999.98 | +286.1% | - | - | |
| May 14, 2020 | Armitage James O | Director | Buy | 10,490 | $1.43 | $15,000.70 | New | - | - | |
| May 14, 2020 | White Lale | Director | Buy | 69,930 | $1.43 | $99,999.90 | New | - | - | |
| May 14, 2020 | Jacob Gary S | Director | Buy | 17,483 | $1.43 | $25,000.69 | +845.0% | - | - |